DelveInsight's, "Malaria Pipeline Insight 2023" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in the Malaria pipeline landscape. It covers the Malaria pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Malaria pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Malaria Pipeline Report
*DelveInsight's Malaria pipeline report depicts a robust space with 15+ active players working to develop 20+ pipeline therapies for Malaria treatment. *The leading companies working in the Malaria Market include
Request a sample and discover the recent advances in Malaria Treatment Drugs @ Malaria Pipeline Report
In the Malaria Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Malaria collaborations, licensing, mergers and acquisition, funding, designations and other product-related details.
Malaria Overview
Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. In 2019, there were an estimated 229 million cases of malaria worldwide. Malaria is caused by Plasmodium parasites.
Find out more about Malaria Therapeutics Assessment @ Malaria Preclinical and Discovery Stage Products
Malaria Emerging Drugs Profile
*Cipargamin:
Malaria Pipeline Therapeutics Assessment
There are approx. 15+ key companies which are developing the Malaria therapies. The Malaria companies that have their Malaria drug candidates in the most advanced stage, i.e. Phase I include
DelveInsight's Malaria Pipeline Report covers around 20+ products under different phases of clinical development like
*Late-stage products (Phase III) *Mid-stage products (Phase II) *Early-stage product (Phase I) along with the details of *Pre-clinical and Discovery stage candidates *Discontinued and inactive candidates
The malaria pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*Intranasal *Intrathecal *Intravenous *Oral *Oral/Intravenous *Parenteral *Subcutaneous *Subcutaneous/Intramuscular *Transdermal
Malaria Pipeline Products have been categorized under various Molecule types such as
*Antisense oligonucleotide *Gene therapy *Hormones *Neuropeptides *Oligonucleotides *Small Molecule *Triglyceride
Learn more about the emerging Malaria Pipeline Therapies @ Malaria Clinical Trials Assessment
Scope of the Malaria Pipeline Report
*Coverage- Global *Malaria Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination *Malaria Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III *Malaria Companies-
Dive deep into rich insights for new drugs for Malaria Treatment, Visit @ Malaria Market Drivers and Barriers, and Future Perspective
Table of Content
*Introduction *Executive Summary *Malaria: Overview *Pipeline Therapeutics *Therapeutic Assessment *Malaria- DelveInsight's Analytical Perspective *Mid Stage Products (Phase II) *PfSPZ Vaccine:
For further information on the Malaria Pipeline therapeutics, reach out to Malaria Unmet Needs and Analyst Views
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company
Contact Person:
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address:
City:
State: NV
Country:
Website: https://www.delveinsight.com/consulting
Source: www.abnewswire.com
.
(C) 2023 M2 COMMUNICATIONS, source